35 results on '"Nguyen, Pauline"'
Search Results
2. Mo1403 - Gender Differences on Long-Term Outcomes in Patients with Dual Chronic Hepatitis B Virus (HBV) and Chronic Hepatitis C Virus (HCV) Infection.
3. 902 - Antiviral Therapy is Under-Utilized but Associated with Improved Survival Across Tumor and Liver Disease Stages and Cancer Therapies in HBV-Related Hepatocellular Carcinoma (HCC): Results of a Multicenter United States Asia Cohort of 2307 Patients.
4. Mo1417 - Ethnic Differences in Overall Survival of Patients with Cirrhosis: Results of a Cohort of 2939 United States Patients with Long-Term Follow-Up.
5. Tu1563 - Trends in Hospital Charges and Encounters for Patients with Nonalcoholic Fatty Liver Disease Compared to Patients with Alcohol Related Liver Disease in the United States Between 2005 and 2013.
6. Sa1476 - High Rate of Progression to Cirrhosis in Chronic Hepatitis B (CHB) Patients with Non-Alcoholic Fatty Liver (FL).
7. Sa1491 - Similar Rates of Complete Viral Suppression (CVS) and Biochemical Response (BR) in Chronic Hepatitis B (CHB) Patients with and Without Nonalcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome (MS).
8. Mo1408 - Temporal Trends in Etiology of Liver Disease, Tumor Characteristics, and Long-Term Survival of Patients with Hepatocellular Carcinoma (HCC): Results of a Single-Center U.S. Cohort from 1997-2016.
9. 904 - Significantly Lower Rates of Cirrhosis and Lower Long-Term Survival in Cryptogenic Hepatocellular Carcinoma (HCC) Compared to Viral Etiologies: Results of a Multi-Center International Cohort.
10. Mo1392 - Ethnic Differences in Disease Presentation and Outcomes in the Setting of Hepatitis C and Hepatitis B Co-Infection.
11. Sa1488 - Differential HBSAG Seroclearance Rates Between Men and Women but not Between Patients Treated with Antiviral Therapy and Untreated Patients: A Systematic Review and Meta-Analysis.
12. 908 - Metabolic Syndrome Increases the Incidence of Cirrhosis and Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B.
13. 1053 - Metabolic Risk Factors Increase the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Cirrhosis.
14. 349 - Antiviral Therapy Reduces Hepatocellular Carcinoma Risk in HBV Cirrhosis Patients with Lower Viral Load.
15. Mo1391 - Higher Rates of Cirrhosis, Hepatic Decompensation, and Hepatocellular Carcinoma (HCC) in Asian and Hispanic Patients with Hepatitis C (HCV) Infection Compared to White and Black Ethnicity Regardless of Gender Differences: A Single Center...
16. Mo1384 - HCV HBV Co-Infection Disproportionately Worsens Cirrhosis, Hepatic Decompensation, and Hepatocellular Carcinoma Incidence in Non-Asians as Compared to Asians.
17. Su1472 - Gender Differences in Outcomes of Cirrhosis in a Large Cohort of Patients in the United States.
18. Mo1421 - Male Sex is a Risk Factor for Poorer Long-Term Overall Survival for White Patients with Hepatocellular Carcinoma (HCC) but not for Black Patients with HCC.
19. Su1476 - Patients with Non-Viral Cirrhosis, Especially Non-Alcoholic Liver Disease and Cryptogenic Cases, had Much Higher Rates of Hepatic Decompensation and Poorer Survival Compared to Patients with Viral Cirrhosis, Despite having Lower HCC Incidence.
20. Mo1409 - Black Patients with Hepatocellular Carcinoma (HCC) Diagnosed After 2010 have Worse Long-Term Survival Than White Patients.
21. 229: Management of dyslipidemia in patients with early rheumatism arthritis. Results of ESPOIR cohort.
22. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B–related Hepatocellular Carcinoma.
23. Sa1541 Regional and Practice Setting Differences in Real-World Treatment Rates of Chronic Hepatitis C (CHC) Infection Worldwide: A Meta-Analysis of 21 Studies and 324,496 Patients.
24. Mo1499 Sex Differences in Disease Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma (HCC).
25. Mo1512 Heterogeneity Among Asian American With Hepatocellular Carcinoma (HCC).
26. Mo1513 Racial and Ethnic Disparities in Etiology of Liver Disease, Tumor Characteristics, and Long-Term Survival of Patients With Hepatocellular Carcinoma (HCC): Results of a Single-Center U.S. Cohort of 1998 Patients.
27. Mo1487 Rising Hospital Charges and Inpatient Encounters for Patients with Hepatocellular Carcinoma (HCC).
28. Mo1498 Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma (HCC) in Maritime South East Asians (MSEAS).
29. Mo1545 Rising Economic Burden of Nonalcoholic Fatty Liver Disease (NAFLD) for Patients in California as Demonstrated by Rising Hospital Charges and Inpatient Encounters.
30. Sa1542 Rising Inpatient Hospital Charges (IHC) in Ethnically Diverse Chronic Hepatitis C (CHC) Patients.
31. 728 Diagnosis by Screening Rather Than Symptoms in Hepatitis B Virus (HBV)-Associated Hepatocellular Carcinoma (HCC) Is Associated With Earlier Stage, More Curative Treatment Options, and Improved Survival, Regardless of Cirrhosis Status.
32. Sa1873 In Hepatitis B Virus (HBV)-Associated Hepatocellular Carcinoma (HCC), Patients With Cirrhosis Have Similar Short-Term but Decreased Long-Term Survival Compared to Those Without Cirrhosis.
33. Frequent Low-Dose Δ9-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood.
34. Functionalizing the γ-position of α-diazo-β-ketoesters.
35. Triethysilyl enol ethers in the synthesis of carbapenem precursors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.